Xue-Hong Zhang

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Cell Cycle Arrest

Oxidative Stress

Transforming Growth Factor

Top Venues

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Li Xia, Jie-Yang Liu, Meng-Ying Yang, Xue-Hong Zhang, Yue Jiang, Qian-Qian Yin, Chen-Hui Luo, Hong-Chen Liu, Zhi-Jie Kang, Cheng-Tao Zhang, Bei-Bei Gao, Ai-Wu Zhou, Hai-Yan Cai, Edmund K Waller, Jin-Song Yan, Ying Lu
Osimertinib covalently binds to CD34 and eliminates myeloid leukemia stem/progenitor cells. Cancer research (2023)
Li-Xue Yang, Cheng-Tao Zhang, Meng-Ying Yang, Xue-Hong Zhang, Hong-Chen Liu, Chen-Hui Luo, Yue Jiang, Zhang-Man Wang, Zhong-Yin Yang, Zhao-Peng Shi, Yi-Ci Yang, Ruo-Qu Wei, Li Zhou, Jun Mi, Ai-Wu Zhou, Zhi-Rong Yao, Li Xia, Jin-Song Yan, Ying Lu
C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse. Blood (2022)